AJP - Regulatory, Integrative and Comparative Physiology, Vol 258, Issue 2 443-R449, Copyright © 1990 by American Physiological Society

ARTICLES

Centrally acting vasopressin contributes to endotoxin tolerance

M. F. Wilkinson and N. W. Kasting
Department of Physiology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Repeated daily intravenous injections of bacterial endotoxin induce a refractory state to their usual pyrogenic effects. The neuropeptide arginine vasopressin (AVP) has been implicated in natural fever suppression and may be involved in the process of pyrogenic tolerance to intravenous endotoxin. This study was conducted to test this hypothesis. Tolerance was induced by two successive daily intravenous injections of Escherichia coli endotoxin (50 micrograms/kg) into conscious unrestrained rats. This tolerance was maintained, unaltered, after a third or fourth subsequent injection. However, bilateral administration of an AVP V1-receptor antagonist (0.43-4.3 nmol) into the ventral septal area (VSA) of the rat brain markedly enhanced the thermoregulatory response to a third or fourth endotoxin challenge compared with saline controls. The effect of the V1 antagonist was dose related. In contrast, an AVP V2 antagonist (0.43 nmol) bilaterally injected into the VSA did not affect the tolerant reaction to endotoxin. Furthermore, neither saline nor the V1 antagonist significantly affected core temperature when administered within the VSA without subsequent endotoxin. These results are consistent with the hypothesis that AVP acts as an endogenous antipyretic within the VSA during fever. Moreover, the data suggest a possible role for centrally acting vasopressin during pyrogenic tolerance to E. coli endotoxin.

This article has been cited by other articles:

				M. B. Dias, M. C. Almeida, E. C. Carnio, and L. G. S. Branco Role of nitric oxide in tolerance to lipopolysaccharide in mice J Appl Physiol, April 1, 2005; 98(4): 1322 - 1327. [Abstract] [Full Text] [PDF]

				M. E. S. Ferreira, M. M. Coelho, and I. R. Pela Role of the hepatic function in the development of the pyrogenic tolerance to muramyl dipeptide Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R162 - R169. [Abstract] [Full Text] [PDF]

				K. C. Bicego-Nahas, A. A. Steiner, E. C. Carnio, J. Antunes-Rodrigues, and L. G. S. Branco Antipyretic effect of arginine vasotocin in toads Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1408 - R1414. [Abstract] [Full Text] [PDF]

				X. Chen, M. Hirasawa, Y. Takahashi, R. Landgraf, and Q. J. Pittman Suppression of PGE2 fever at near term: reduced thermogenesis but not enhanced vasopressin antipyresis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R354 - R361. [Abstract] [Full Text] [PDF]

				A. A. Steiner, E. C. Carnio, J. Antunes-Rodrigues, and L. G. S. Branco Endogenous vasopressin does not mediate hypoxia-induced anapyrexia in rats J Appl Physiol, February 1, 1999; 86(2): 469 - 473. [Abstract] [Full Text] [PDF]